| Role |
Name |
Disclosure |
Details |
| Author | George T Griffing, MD, Professor of Medicine, St Louis University School of Medicine | Nothing to disclose | Details | | Coauthor | Robert A Gabbay, MD, PhD, Associate Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, Laurence M Demers Career Development Professor, Penn State College of Medicine; Director, Diabetes Program, Penn State Milton S Hershey Medical Center; Executive Director, Penn State Institute for Diabetes and Obesity | Pfizer, Novo Nordisk, Merck | Details | | Medical Editor | Amir E Harari, MD, Staff Physician, Endocrinology Division, Instructor, Department of Clinical Medicine, Naval Medical Center at San Diego | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences, George Mason University; Principal, C/A Informatics, LLC | Nothing to disclose | Details | | CME Editor | Mark Cooper, MBBS, PhD, FRACP, Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, St Louis University School of Medicine | Nothing to disclose | Details |
|